| Awdur (Corfforaethol) | European Medicines Agency |
|---|---|
| Teitl y Gyfres | Press Release |
| Manylion y Gyfres | EMA/CHMP/717405/2012 (16.11.12) |
| Dyddiad Cyhoeddi | 16/11/2012 |
| Math o Gynnwys | News |
|
The European Medicines Agency (EMA), in November 2012, finalised a review into the supply chain for protamine-containing medicinal products and concluded that there would be no supply shortage for medicinal products containing protamine in the European Union (EU). Protamine sulphate is used to counteract the anticoagulant action of heparin in the treatment of bleeding resulting from heparin overdose. It is also used to neutralise the effect of heparin, particularly in cardiac surgery. |
|
| Dolen Ffynhonnell | Link to Main Source http://www.emea.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/11/news_detail_001657.jsp&mid=WC0b01ac058004d5c1 |
| Dolenni Cysylltiedig |
|
| Categorïau Pwnc | Health |
| Gwledydd / Rhanbarthau | Europe |
